CNBC's Stock Pops & Drops From September 26

Speaking on CNBC's Stock Pops & Drops, Guy Adami said that it would not be wise to chase Agios Pharmaceuticals Inc AGIO after the stock spiked 19.29 percent. The company announced new clinical data on its cancer drug. In the biotech space, Adami likes Celgene Corporation CELG and Gilead Sciences, Inc. GILD. Tim Seymour has a long position in Altria Group Inc MO and he is keeping it after the stock jumped 1.55 percent. He also said that the company owns 20 percent in SABMiller and that investment is pumping up the value. Altria Group Inc got upgraded on Friday by Bank of America Corp BAC. Pfizer Inc. PFE dropped 0.87 percent on the news that there will be a significant delay of the development of its sickle cell drug. Pete Najarian thinks that it was just a slight drop and he still likes the stock because it is trading at 13 forward earnings. He added that Pfizer Inc. was his final trade on Thursday and he likes it more after the pull back. Micron Technology, Inc. MU spiked 6.72 percent after the earnings and it closed the session at $33.38. Brian Kelly thinks that the stock is going to $35.